NewEdge Wealth’s CVS Health CVS Stock Holding History

NewEdge Wealth’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05M	Sell	14,603 -10,496	-42%	-$809K	0.01%	614
2025 Q4	$1.99M	Buy	25,099 +8,200	+49%	+$646K	0.02%	448
2025 Q3	$1.33M	Sell	16,899 -18,855	-53%	-$1.29M	0.02%	496
2025 Q2	$2.27M	Buy	35,754 +20,983	+142%	+$1.38M	0.04%	354
2025 Q1	$1M	Buy	14,771 +376	+3%	+$22.5K	0.02%	485
2024 Q4	$646K	Buy	14,395 +908	+7%	+$50.9K	0.01%	581
2024 Q3	$848K	Buy	13,487 +2,644	+24%	+$154K	0.02%	506
2024 Q2	$640K	Sell	10,843 -4,559	-30%	-$285K	0.01%	491
2024 Q1	$849K	Sell	15,402 -523	-3%	-$40K	0.02%	453
2023 Q4	$1.26M	Sell	15,925 -2,061	-11%	-$147K	0.03%	366
2023 Q3	$1.26M	Sell	17,986 -2,441	-12%	-$173K	0.04%	322
2023 Q2	$1.41M	Buy	20,427 +1,819	+10%	+$129K	0.05%	310
2023 Q1	$1.38M	Sell	18,608 -152	-0.8%	-$12.7K	0.05%	275
2022 Q4	$1.75M	Buy	18,760 +2,429	+15%	+$234K	0.08%	229
2022 Q3	$1.56M	Buy	16,331 +7,158	+78%	+$709K	0.07%	224
2022 Q2	$850K	Buy	9,173 +5,467	+148%	+$534K	0.04%	305
2022 Q1	$375K	Buy	3,706 +640	+21%	+$67.2K	0.02%	336
2021 Q4	$316K	Buy	+3,066	New	+$283K	0.01%	336

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NewEdge Wealth's CVS Position: Q1 2026 in Review

NewEdge Wealth reduced its CVS Health (CVS) stake by 42% in Q1 2026, selling an estimated $809K and leaving 14,603 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #614.

NewEdge Wealth first reported a position in CVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.27M in Q2 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

NewEdge Wealth held 14,603 shares of CVS Health worth $1.05M as of Q1 2026.
NewEdge Wealth sold 10,496 CVS Health shares in Q1 2026, an estimated $809K.
CVS Health made up 0.01% of NewEdge Wealth's portfolio in Q1 2026, its #614 holding.
NewEdge Wealth first reported a position in CVS Health in Q4 2021 and has held it in 18 quarters since.
NewEdge Wealth's CVS Health position peaked at $2.27M in Q2 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.